SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-005952
Filing Date
2021-03-15
Accepted
2021-03-15 08:00:18
Documents
14
Period of Report
2021-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42139
2 ex3-1.htm EX-3.1 4493
3 ex99-1.htm EX-99.1 74193
  Complete submission text file 0001493152-21-005952.txt   312421

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE corbuspharmacom-20210314.xsd EX-101.SCH 3232
5 XBRL LABEL FILE corbuspharmacom-20210314_lab.xml EX-101.LAB 35274
6 XBRL PRESENTATION FILE corbuspharmacom-20210314_pre.xml EX-101.PRE 23166
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3815
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 21739865
SIC: 2834 Pharmaceutical Preparations